Cargando…
Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study
OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398114/ https://www.ncbi.nlm.nih.gov/pubmed/30868117 http://dx.doi.org/10.1002/epi4.12286 |
_version_ | 1783399530981490688 |
---|---|
author | Nabbout, Rima Belousova, Elena Benedik, Mirjana P. Carter, Tom Cottin, Vincent Curatolo, Paolo Dahlin, Maria D´Amato, Lisa d'Augères, Guillaume Beaure de Vries, Petrus J. Ferreira, José C. Feucht, Martha Fladrowski, Carla Hertzberg, Christoph Jozwiak, Sergiusz Lawson, John A. Macaya, Alfons Marques, Ruben O'Callaghan, Finbar Qin, Jiong Sander, Valentin Sauter, Matthias Shah, Seema Takahashi, Yukitoshi Touraine, Renaud Youroukos, Sotiris Zonnenberg, Bernard Jansen, Anna Kingswood, John C. |
author_facet | Nabbout, Rima Belousova, Elena Benedik, Mirjana P. Carter, Tom Cottin, Vincent Curatolo, Paolo Dahlin, Maria D´Amato, Lisa d'Augères, Guillaume Beaure de Vries, Petrus J. Ferreira, José C. Feucht, Martha Fladrowski, Carla Hertzberg, Christoph Jozwiak, Sergiusz Lawson, John A. Macaya, Alfons Marques, Ruben O'Callaghan, Finbar Qin, Jiong Sander, Valentin Sauter, Matthias Shah, Seema Takahashi, Yukitoshi Touraine, Renaud Youroukos, Sotiris Zonnenberg, Bernard Jansen, Anna Kingswood, John C. |
author_sort | Nabbout, Rima |
collection | PubMed |
description | OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of TSC were collected from multiple countries worldwide. Epilepsy variables included seizure type, age at onset, type of treatment, and treatment outcomes and association with genotype, seizures control, and intellectual disability. As for noninterventional registries, the study protocol did not specify any particular clinical instruments, laboratory investigations, or intervention. Evaluations included those required for diagnosis and management following local best practice. RESULTS: Epilepsy was reported in 83.6% of patients (1852/2216) at baseline; 38.9% presented with infantile spasms and 67.5% with focal seizures. The mean age at diagnosis of infantile spasms was 0.4 year (median <1 year; range <1‐30 years) and at diagnosis of focal seizures was 2.7 years (median 1 year; range <1‐66 years). A total of 1469 patients (79.3%) were diagnosed with epilepsy <2 years. The rate of infantile spasms was higher in patients with a TSC 2 mutation than in patients with a TSC1 mutation (47.3% vs 23%). ɣ‐aminobutyric acid (GABA)ergic drugs were the most common treatment modality for both infantile spasms (78.7%) and focal seizures (65.5%). Infantile spasms and focal seizures were controlled in 76.3% and 58.2% of patients, respectively. Control of seizures was associated with lower rates of intellectual disability in both groups. SIGNIFICANCE: This registry reports the largest international cohort of patients with TSC. Findings confirmed the typical onset pattern of infantile spasms and other focal seizures in the first 2 years of life, and the high rates of infantile spasms in patients with TSC2 mutation. Our results underscored the occurrence of focal seizures at all ages, including an onset that preceded emergence of infantile spasms. Seizure control was shown to be associated with lower rates of intellectual disability but did not preclude the presence of intellectual disability. |
format | Online Article Text |
id | pubmed-6398114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63981142019-03-13 Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study Nabbout, Rima Belousova, Elena Benedik, Mirjana P. Carter, Tom Cottin, Vincent Curatolo, Paolo Dahlin, Maria D´Amato, Lisa d'Augères, Guillaume Beaure de Vries, Petrus J. Ferreira, José C. Feucht, Martha Fladrowski, Carla Hertzberg, Christoph Jozwiak, Sergiusz Lawson, John A. Macaya, Alfons Marques, Ruben O'Callaghan, Finbar Qin, Jiong Sander, Valentin Sauter, Matthias Shah, Seema Takahashi, Yukitoshi Touraine, Renaud Youroukos, Sotiris Zonnenberg, Bernard Jansen, Anna Kingswood, John C. Epilepsia Open Full‐length Original Research OBJECTIVE: To present the baseline data of the international TuberOus SClerosis registry to increase disease Awareness (TOSCA) with emphasis on the characteristics of epilepsies associated with tuberous sclerosis complex (TSC). METHODS: Retrospective and prospective patients’ data on all aspects of TSC were collected from multiple countries worldwide. Epilepsy variables included seizure type, age at onset, type of treatment, and treatment outcomes and association with genotype, seizures control, and intellectual disability. As for noninterventional registries, the study protocol did not specify any particular clinical instruments, laboratory investigations, or intervention. Evaluations included those required for diagnosis and management following local best practice. RESULTS: Epilepsy was reported in 83.6% of patients (1852/2216) at baseline; 38.9% presented with infantile spasms and 67.5% with focal seizures. The mean age at diagnosis of infantile spasms was 0.4 year (median <1 year; range <1‐30 years) and at diagnosis of focal seizures was 2.7 years (median 1 year; range <1‐66 years). A total of 1469 patients (79.3%) were diagnosed with epilepsy <2 years. The rate of infantile spasms was higher in patients with a TSC 2 mutation than in patients with a TSC1 mutation (47.3% vs 23%). ɣ‐aminobutyric acid (GABA)ergic drugs were the most common treatment modality for both infantile spasms (78.7%) and focal seizures (65.5%). Infantile spasms and focal seizures were controlled in 76.3% and 58.2% of patients, respectively. Control of seizures was associated with lower rates of intellectual disability in both groups. SIGNIFICANCE: This registry reports the largest international cohort of patients with TSC. Findings confirmed the typical onset pattern of infantile spasms and other focal seizures in the first 2 years of life, and the high rates of infantile spasms in patients with TSC2 mutation. Our results underscored the occurrence of focal seizures at all ages, including an onset that preceded emergence of infantile spasms. Seizure control was shown to be associated with lower rates of intellectual disability but did not preclude the presence of intellectual disability. John Wiley and Sons Inc. 2018-12-21 /pmc/articles/PMC6398114/ /pubmed/30868117 http://dx.doi.org/10.1002/epi4.12286 Text en © 2018 The Authors. Epilepsia Open published by Wiley Periodicals Inc. on behalf of International League Against Epilepsy. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Full‐length Original Research Nabbout, Rima Belousova, Elena Benedik, Mirjana P. Carter, Tom Cottin, Vincent Curatolo, Paolo Dahlin, Maria D´Amato, Lisa d'Augères, Guillaume Beaure de Vries, Petrus J. Ferreira, José C. Feucht, Martha Fladrowski, Carla Hertzberg, Christoph Jozwiak, Sergiusz Lawson, John A. Macaya, Alfons Marques, Ruben O'Callaghan, Finbar Qin, Jiong Sander, Valentin Sauter, Matthias Shah, Seema Takahashi, Yukitoshi Touraine, Renaud Youroukos, Sotiris Zonnenberg, Bernard Jansen, Anna Kingswood, John C. Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title | Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title_full | Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title_fullStr | Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title_full_unstemmed | Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title_short | Epilepsy in tuberous sclerosis complex: Findings from the TOSCA Study |
title_sort | epilepsy in tuberous sclerosis complex: findings from the tosca study |
topic | Full‐length Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398114/ https://www.ncbi.nlm.nih.gov/pubmed/30868117 http://dx.doi.org/10.1002/epi4.12286 |
work_keys_str_mv | AT nabboutrima epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT belousovaelena epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT benedikmirjanap epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT cartertom epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT cottinvincent epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT curatolopaolo epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT dahlinmaria epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT damatolisa epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT daugeresguillaumebeaure epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT devriespetrusj epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT ferreirajosec epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT feuchtmartha epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT fladrowskicarla epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT hertzbergchristoph epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT jozwiaksergiusz epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT lawsonjohna epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT macayaalfons epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT marquesruben epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT ocallaghanfinbar epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT qinjiong epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT sandervalentin epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT sautermatthias epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT shahseema epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT takahashiyukitoshi epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT tourainerenaud epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT youroukossotiris epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT zonnenbergbernard epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT jansenanna epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT kingswoodjohnc epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy AT epilepsyintuberoussclerosiscomplexfindingsfromthetoscastudy |